Back
-
ZLN005 alleviates in vivo and in vitro renal fibrosis via PGC-1α-mediated mitochondrial homeostasis
Product used: EZ Trans cell transfection reagent (efficient)PharmaceuticalsDetails
-
Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells
Product used: EZ ECL pico chemiluminescent liquid (super sensitive)Signal Transduction and Targeted TherapyDetails
-
Salvianolate ameliorates renal tubular injury through the Keap1/Nrf2/ARE pathway in mouse kidney ischemia-reperfusion injury
Product used: EZ cell transfection reagentJournal of EthnopharmacologyDetails
-
High-frequency repetitive transcranial magnetic stimulation mitigates depression-like behaviors in CUMS-induced rats via FGF2/FGFR1/p-ERK signaling pathway
Product used: Phosphatase inhibitor II cocktail (50 x)Brain Research BulletinDetails
-
Overexpression of TP53INP2 promotes apoptosis in clear cell renal cell cancer via caspase-8/TRAF6 signaling pathway
Product used: BCA protein quantification kitJournal of Immunology ResearchDetails
-
Girdin Promotes Tumorigenesis and Chemoresistance in Lung Adenocarcinoma by Interacting with PKM2
Product used: EZ lentivirus concentrateCancersDetails
-
Integrating network pharmacology and experimental models to examine the mechanisms of corosolic acid in preventing hepatocellular carcinoma progression through …
Product used: EZ ECL Chemiluminescence Liquid (Enhanced)Naunyn-Schmiedeberg's Archives of PharmacologyDetails
-
Golgin45 SUMOylation Contributes To PML Nuclear Body Formation During Heat Shock Response
Product used: EZ lentivirus concentrateJournal of Proteome ResearchDetails
-
Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma
Product used: Hepes Tris protein preform adhesive (precise concentration, glass plate)Cell Death & DiseaseDetails
-
ZDHHC2-Mediated AGK Palmitoylation Activates AKT–mTOR Signaling to Reduce Sunitinib Sensitivity in Renal Cell Carcinoma
Product used: Premium Fetal Bovine Serum (FBS)Cancer ResearchDetails
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
